WO2000050565A3 - Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs - Google Patents
Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs Download PDFInfo
- Publication number
- WO2000050565A3 WO2000050565A3 PCT/US2000/004950 US0004950W WO0050565A3 WO 2000050565 A3 WO2000050565 A3 WO 2000050565A3 US 0004950 W US0004950 W US 0004950W WO 0050565 A3 WO0050565 A3 WO 0050565A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- tumor suppressor
- kits
- compositions
- methods relating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002361396A CA2361396A1 (fr) | 1999-02-25 | 2000-02-25 | Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs |
JP2000601129A JP2003508011A (ja) | 1999-02-25 | 2000-02-25 | ヒトfez1遺伝子である新規ガン抑制遺伝子に関する組成物、キットおよび方法 |
EP00912007A EP1163252A4 (fr) | 1999-02-25 | 2000-02-25 | Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12153799P | 1999-02-25 | 1999-02-25 | |
US60/121,537 | 1999-02-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000050565A2 WO2000050565A2 (fr) | 2000-08-31 |
WO2000050565A3 true WO2000050565A3 (fr) | 2000-12-07 |
Family
ID=22397335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/004950 WO2000050565A2 (fr) | 1999-02-25 | 2000-02-25 | Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1163252A4 (fr) |
JP (1) | JP2003508011A (fr) |
CA (1) | CA2361396A1 (fr) |
WO (1) | WO2000050565A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8911998B2 (en) | 2007-10-26 | 2014-12-16 | The Ohio State University | Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof |
US9125923B2 (en) | 2008-06-11 | 2015-09-08 | The Ohio State University | Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7141417B1 (en) | 1999-02-25 | 2006-11-28 | Thomas Jefferson University | Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene |
EP2719773A3 (fr) | 2007-06-15 | 2014-07-30 | The Ohio State University Research Foundation | Protéines de fusion all-1 oncogènes pour cibler le traitement de micro-arn régulé par drosha |
US8465918B2 (en) | 2007-08-03 | 2013-06-18 | The Ohio State University Research Foundation | Ultraconserved regions encoding ncRNAs |
CA2781547A1 (fr) | 2009-11-23 | 2011-05-26 | The Ohio State University | Substances et procedes pouvant s'utiliser pour agir sur la croissance, la migration, et l'invasion de cellules tumorales |
WO2012065049A1 (fr) | 2010-11-12 | 2012-05-18 | The Ohio State University Research Foundation | Matériaux et procédés relatifs aux microarn-21, réparation de désappariement et cancer colorectal |
JP2014500258A (ja) | 2010-11-15 | 2014-01-09 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 制御放出粘膜付着システム |
CN103561750A (zh) | 2011-03-07 | 2014-02-05 | 俄亥俄州立大学 | 通过microRNA-155(miR-155)诱导的增变活性使炎症与癌症关联 |
EP2766500A4 (fr) | 2011-10-14 | 2015-10-14 | Univ Ohio State | Méthodes et matériaux relatifs au cancer des ovaires |
US9481885B2 (en) | 2011-12-13 | 2016-11-01 | Ohio State Innovation Foundation | Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis |
JP2015511121A (ja) | 2012-01-20 | 2015-04-16 | ジ・オハイオ・ステート・ユニバーシティ | 浸潤性および予後に関する乳がんバイオマーカーシグネチャー |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001055300A2 (fr) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Acides nucleiques, proteines et anticorps |
CA2395872A1 (fr) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Acides nucleiques, proteines et anticorps |
-
2000
- 2000-02-25 JP JP2000601129A patent/JP2003508011A/ja active Pending
- 2000-02-25 CA CA002361396A patent/CA2361396A1/fr not_active Abandoned
- 2000-02-25 EP EP00912007A patent/EP1163252A4/fr not_active Withdrawn
- 2000-02-25 WO PCT/US2000/004950 patent/WO2000050565A2/fr active Application Filing
Non-Patent Citations (5)
Title |
---|
DATABASE GENBANK ISHII ET AL.: "The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein and its expression is altered in multiple human tumors", XP002950674 * |
DATABASE GENBANK ISHII ET AL.: "The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein and its expression is altered in multiple human tumors", XP002950675 * |
DATABASE GENBANK WANG ET AL.: "Large-scale indentification, mapping and genotyping of single-nucleotide polymorphiosms in the human genome", XP002950673 * |
PROC. NATL. ACAD. SCI. USA, vol. 96, no. 7, 1999, pages 3928 - 3933 * |
SCIENCE, vol. 280, no. 5366, 1998, pages 1077 - 1082 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8911998B2 (en) | 2007-10-26 | 2014-12-16 | The Ohio State University | Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof |
US9125923B2 (en) | 2008-06-11 | 2015-09-08 | The Ohio State University | Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy |
Also Published As
Publication number | Publication date |
---|---|
CA2361396A1 (fr) | 2000-08-31 |
WO2000050565A2 (fr) | 2000-08-31 |
JP2003508011A (ja) | 2003-03-04 |
EP1163252A2 (fr) | 2001-12-19 |
EP1163252A4 (fr) | 2004-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1005540A4 (fr) | Proteines ikk-beta, acides nucleiques et procedes | |
WO2004076639A3 (fr) | Compositions et methodes destinees a diagnostiquer et traiter des maladies auto-immunes | |
WO2000055180A3 (fr) | Sequences et polypeptides geniques associes au cancer du poumon chez l'homme | |
EP1440981A3 (fr) | ADN complementaire humaine de pleine longueur | |
WO2000040614A3 (fr) | Caracterisation d'une famille de canaux calciques | |
WO1999053040A3 (fr) | Sequences d'acide nucleique humain provenant de tissu de tumeur ovarienne | |
WO2003016475A3 (fr) | Sequences d'acides nucleiques et d'acides amines intervenant dans la douleur | |
WO2000050565A3 (fr) | Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs | |
AU1367095A (en) | Effector proteins of rapamycin | |
WO2001055308A3 (fr) | Acides nucleiques, proteines et anticorps | |
WO2002095051A3 (fr) | Peptides mage-a3 presentes par des molecules hla de classe ii | |
WO1999047669A3 (fr) | Sequences d'acide nucleique humain tirees de tissus de tumeurs du sein | |
CA2295999A1 (fr) | Proteines nik, acides nucleiques et procedes correspondants | |
CA2079454A1 (fr) | Steroide-5.alpha. reductase | |
EP1163515A4 (fr) | Outils diagnostiques et therapeutiques permettant de traiter les troubles de la tolerance glucidique | |
WO1999027098A3 (fr) | Antigenes apparentes a a33 et leurs utilisations pharmacologiques | |
WO1998059040A3 (fr) | Sous-unite de telomerase catalytique humaine et son utilisation therapeutique et diagnostique | |
WO2002061144A3 (fr) | Diagnostic de tumeur cerebrale et prediction de resultat de traitement | |
WO1998011234A3 (fr) | Proteines kinases humaines | |
EP1447413A3 (fr) | ADN complementaire humaine de pleine longueur | |
WO2005058251A3 (fr) | Anticorps specifiques de hla-dr, compositions et methodes associees | |
WO1999046374A3 (fr) | Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques | |
WO1997031111A3 (fr) | Famille de transporteurs d'anions organiques, acides nucleiques codant ceux-ci, cellules les comprenant et procedes d'utilisation associes | |
WO2002010388A3 (fr) | Molecules du type recepteur de complement c3b/c4b et utilisations de ces molecules | |
WO1998025956A3 (fr) | Nouvelles proteines humaines se liant a la guanosine triphosphate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref document number: 2361396 Country of ref document: CA Ref country code: CA Ref document number: 2361396 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 601129 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000912007 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000912007 Country of ref document: EP |